Videos

Here are the top 5 biosimilar articles for the week of February 17, 2025.

Travis Brewer, vice president of payer and public health strategy at Texas Oncology, discusses the role of biosimilars in making cancer care more affordable and accessible, as well as the need for greater payer trust in oncologists’ treatment decisions.

Here are the top 5 biosimilar articles for the week of February 10, 2025.

Here are the top 5 biosimilar articles for the week of February 3, 2025.

Josh Canavan, PharmD, head of pharmacy at RazorMetrics, recommends key educational resources for biosimilars, and emphasizes the extensive research conducted before pharmacy benefit managers (PBMs) add medications, including biosimilars, to their formularies.

Here are the top 5 biosimilar articles for the week of January 27, 2025.

Here are the top 5 biosimilar articles for the week of January 20, 2025.

Here are the top 5 biosimilar articles for the week of January 13, 2025.

Here are the top 5 biosimilar articles for the week of January 6, 2025.

Tiago Biachi, MD, PhD, emphasizes that biosimilars are vital for reducing financial toxicity and ensuring equitable, affordable access to advanced treatments in gastrointestinal (GI) cancer care, while calling for dynamic policies and greater cost awareness among clinicians.

Here are the top 5 biosimilar articles for the week of December 30, 2024.

Here are the top 5 biosimilar articles for the week of December 16, 2024.

Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discussed barriers to biosimilar adoption and highlighted strategies such as physician education, streamlined implementation, payer collaboration, and patient engagement to improve access, reduce costs, and enhance adherence to biologic therapies.

Here are the top 5 biosimilar articles for the week of December 9, 2024.

Steve Pickette, PharmD, BCPS, emphasizes that AI can streamline prescribing and formulary management for biosimilars and generics, enhance provider engagement, and improve pharmacovigilance by tracking adoption rates and identifying potential issues.

Here are the top 5 biosimilar articles for the week of December 2, 2024.

Here are the top 5 biosimilar articles for the week of November 25, 2024.

Here are the top 5 biosimilar articles for the week of November 18, 2024.

This webinar celebrating Global Biosimilars Week was hosted by The Center for Biosimilars® in partnership with the International Generics and Biosimilars Association.

Here are the top 5 biosimilar articles for the week of November 11, 2024.

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, discusses how integrated delivery networks (IDNs) can help drive biosimilar adoption.

Here are the top 5 biosimilar articles for the week of November 4, 2024.

Here are the top 5 biosimilar articles for the week of October 28, 2024.

Here are the top 5 biosimilar articles for the week of October 21, 2024.

Sophia Humphreys, PharmD, from Sutter Health explains that expanding biosimilars into new therapeutic areas faces hesitance due to maintenance therapies, emphasizing the importance of education.

Here are the top 5 biosimilar articles for the week of October 14, 2024.

Ivo Abraham, PhD, RN, director of the Center for Health Outcomes and PharmacoEconomic Research at the University of Arizona Cancer Center, discusses the potential of biosimilars and challenges in the US, emphasizing partnerships for market growth.

Here are the top 5 biosimilar articles for the week of October 7, 2024.

Here are the top 5 biosimilar articles for the week of September 30, 2024.